对乙酰氨基酚
医学
药方
肝衰竭
重症监护医学
药物过量
药品
肝损伤
急诊科
药理学
麻醉
医疗急救
毒物控制
内科学
精神科
标识
DOI:10.1016/j.jhep.2017.07.005
摘要
Acetaminophen (APAP) is the most commonly used drug for the treatment of pain and fever around the world. At the same time, APAP can cause dose-related hepatocellular necrosis, responsible for nearly 500 deaths annually in the United States (US) alone, as well as 100,000 calls to US Poison Control Centers, 50,000 emergency room visits and 10,000 hospitalisations per year. As an over-the-counter and prescription product (with opioids), APAP toxicity dwarfs all other prescription drugs as a cause of acute liver failure in the US and Europe, but it is not regulated in any significant way. In this review the ongoing controversy surrounding the proper role for this ubiquitous pain reliever: its history, pathogenesis, clinical challenges in recognition and management, and current regulatory status are highlighted. A new solution to a 50-year-old problem is proposed.
科研通智能强力驱动
Strongly Powered by AbleSci AI